Items where authors include "Kent, M."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Fotios, S. orcid.org/0000-0002-2410-7641 and Kent, M. (2021) Measuring discomfort from glare: recommendations for good practice. LEUKOS, 17 (4). pp. 338-358. ISSN 1550-2724

Kent, M., Fotios, S. orcid.org/0000-0002-2410-7641 and Altomonte, S. (2019) Discomfort glare evaluation: The influence of anchor bias in luminance adjustments. Lighting Research & Technology, 51 (1). pp. 131-146. ISSN 1477-1535

Kent, M., Fotios, S. orcid.org/0000-0002-2410-7641 and Altomonte, S. (2019) An experimental study on the effect of visual tasks on discomfort due to peripheral glare. LEUKOS - Journal of Illuminating Engineering Society of North America, 15 (1). pp. 17-28. ISSN 0099-4480

Kent, M., Fotios, S. orcid.org/0000-0002-2410-7641 and Altomonte, S. (2018) Order effects when using Hopkinson’s multiple criterion scale of discomfort due to glare. Building and Environment, 136. pp. 56-61. ISSN 0360-1323

Proceedings Paper

Kent, M., Fotios, S. orcid.org/0000-0002-2410-7641 and Altomonte, S. (2018) Experimental biases in discomfort glare evaluations. In: 34th International Conference on Passive and Low Energy Architecture (PLEA). PLEA 2018, 10-12 Dec 2018, Hong Kong. PLEA .